Showing 341 - 360 results of 8,153 for search '"tumor"', query time: 0.09s Refine Results
  1. 341

    Inhibitory Effects of Apigenin on Tumor Carcinogenesis by Altering the Gut Microbiota by Shichang Bian, Hongjuan Wan, Xinyan Liao, Weisheng Wang

    Published 2020-01-01
    “…The size and quantity of tumors were reduced significantly in the apigenin treatment group. …”
    Get full text
    Article
  2. 342
  3. 343

    Risk factors for fluorouracil-induced cardiotoxicity in patients with gastrointestinal tumor by Yuting Wu, Chen Lv, Jindong Li, Ying Ma, Xiaoli Zhu

    Published 2025-02-01
    “…ObjectiveTo explore the risk factors for cardiotoxicity in patients with gastrointestinal (GI) tumors treated with fluorouracil drugs.MethodsThis study included patients with GI tumors who received fluorouracil at our hospital between January 2018 and April 2022. …”
    Get full text
    Article
  4. 344

    Ensemble Deep Learning Technique for Detecting MRI Brain Tumor by Rasool Fakhir Jader, Shahab Wahhab Kareem, Hoshang Qasim Awla

    Published 2024-01-01
    “…As a result, MRI brain tumor segmentation is more precise because each spatial feature point can now refer to all other contextual data. …”
    Get full text
    Article
  5. 345

    Dentinogenic Ghost Cell Tumor of the Peripheral Variant Mimicking Epulis by Uddipan Kumar, Hitesh Vij, Ruchieka Vij, Jitin Kharbanda, IN Aparna, Raghu Radhakrishnan

    Published 2010-01-01
    “…Dentinogenic ghost cell tumor (DGCT) is an uncommon locally invasive odontogenic tumor regarded by many as a variant of calcifying odontogenic cyst. …”
    Get full text
    Article
  6. 346

    Cauda equina neuroendocrine tumor: Report of a rare case by Guoyun Zhao, Zhengliang Fan, Qinghua Zou, Rong Yang

    Published 2025-02-01
    Subjects: “…Cauda equina neuroendocrine tumors…”
    Get full text
    Article
  7. 347
  8. 348
  9. 349

    Adrenal Rest Tumor of the Liver Preoperatively Diagnosed as Hepatocellular Carcinoma by Megumu Enjoji, Katsuya Sanada, Ryota Seki, Takashi Ito, Masato Maeda

    Published 2017-01-01
    “…Hepatic adrenal rest tumors are rare and show similar findings to hepatocellular carcinoma (HCC). …”
    Get full text
    Article
  10. 350

    Treatment Choices for Tenosynovial Giant Cell Tumor: Surgery or Observation? by Hairong XU, Jing CHEN, Xiaohui NIU

    Published 2025-01-01
    Subjects: “…tenosynovial giant cell tumor…”
    Get full text
    Article
  11. 351

    Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma by Zeynep Kacar, Eric Slud, Doron Levy, Julián Candia, Anuradha Budhu, Marshonna Forgues, Xiaolin Wu, Arati Raziuddin, Bao Tran, Jyoti Shetty, Yotsawat Pomyen, Jittiporn Chaisaingmongkol, Siritida Rabibhadana, Benjarath Pupacdi, Vajarabhongsa Bhudhisawasdi, Nirush Lertprasertsuke, Chirayu Auewarakul, Suleeporn Sangrajrang, Chulabhorn Mahidol, Mathuros Ruchirawat, Xin Wei Wang

    Published 2024-03-01
    “…Abstract Hepatocellular carcinoma (HCC) is a molecularly heterogeneous solid malignancy, and its fitness may be shaped by how its tumor cells evolve. However, ability to monitor tumor cell evolution is hampered by the presence of numerous passenger mutations that do not provide any biological consequences. …”
    Get full text
    Article
  12. 352

    Population pharmacokinetics of iruplinalkib in healthy volunteers and patients with solid tumors by Guihong Yang, Yimei Wang, Huimin Zhao, Ziyi Jiang, Shansong Zheng, Mingjing Ge, Meimei Si, Xiaoyan Kang

    Published 2025-01-01
    “…Plasma concentration–time data were collected from 392 participants (16 healthy volunteers and 372 patients with solid tumors) who received single or multiple doses of iruplinalkib in four trials. …”
    Get full text
    Article
  13. 353

    Harnessing nanoparticles for reshaping tumor immune microenvironment of hepatocellular carcinoma by JinSong Li, GuanBo Zhang, Gang Li, Jie Zhang, Zhi Yang, Lin Yang, ShiJie Jiang, JiaXing Wang

    Published 2025-02-01
    “…However, acquired resistance and the tumor immunosuppressive microenvironment (TIME) significantly hinder its clinical application. …”
    Get full text
    Article
  14. 354

    The Role and Therapeutic Potential of Endothelial Progenitor Cells in Tumor Neovascularization by Branislava Janic, Ali S. Arbab

    Published 2010-01-01
    “…Although the cellular and molecular mechanisms of tumor growth and metastasis are not completely understood, it is established that formation and growth of new blood vessels is a conditio sine qua non for tumor survival, growth, and expansion. …”
    Get full text
    Article
  15. 355

    Endometrioid Paraovarian Borderline Cystic Tumor in an Infant with Proteus Syndrome by Liliana Vasquez, Mariela Tello, Ivan Maza, Monica Oscanoa, Milagros Dueñas, Haydee Castro, Alan Latorre

    Published 2015-01-01
    “…Ovarian and paraovarian neoplasms are uncommon in children, mainly originating from germ cell tumors and, least frequently, epithelial tumors. There is an association between genital tract tumors and Proteus syndrome, a rare, sporadic, and progressive entity, characterized by a postnatal overgrowth in several tissues caused by a mosaic mutation in the AKT1 gene. …”
    Get full text
    Article
  16. 356

    Advances in sodium-glucose transporter protein 2 inhibitors and tumors by Jiaqi Wang, Wenyong Yang

    Published 2025-02-01
    “…Tumor is a major challenge to global health and has received extensive attention worldwide due to its high degree of malignancy and poor prognosis. …”
    Get full text
    Article
  17. 357
  18. 358
  19. 359
  20. 360